These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 1850928)
1. Expression of the outer capsid protein VP5 of two bluetongue viruses, and synthesis of chimeric double-shelled virus-like particles using combinations of recombinant baculoviruses. Loudon PT; Hirasawa T; Oldfield S; Murphy M; Roy P Virology; 1991 Jun; 182(2):793-801. PubMed ID: 1850928 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of recombinant baculoviruses expressing the outer capsid protein VP2 of five BTV serotypes and the induction of neutralizing antibodies to homologous and heterologous BTV serotypes. Urakawa T; French TJ; Adachi Y; Fukusho A; LeBlois H; Flamand M; Mertens P; Roy P Virus Res; 1994 Feb; 31(2):149-61. PubMed ID: 8178571 [TBL] [Abstract][Full Text] [Related]
3. Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection. Stewart M; Dovas CI; Chatzinasiou E; Athmaram TN; Papanastassopoulou M; Papadopoulos O; Roy P Vaccine; 2012 Mar; 30(12):2131-9. PubMed ID: 22285887 [TBL] [Abstract][Full Text] [Related]
4. Assembly of five bluetongue virus proteins expressed by recombinant baculoviruses: inclusion of the largest protein VP1 in the core and virus-like proteins. Loudon PT; Roy P Virology; 1991 Feb; 180(2):798-802. PubMed ID: 1846500 [TBL] [Abstract][Full Text] [Related]
5. Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection. Roy P; Bishop DH; LeBlois H; Erasmus BJ Vaccine; 1994 Jul; 12(9):805-11. PubMed ID: 7975859 [TBL] [Abstract][Full Text] [Related]
6. Assembly of double-shelled, viruslike particles of bluetongue virus by the simultaneous expression of four structural proteins. French TJ; Marshall JJ; Roy P J Virol; 1990 Dec; 64(12):5695-700. PubMed ID: 2173762 [TBL] [Abstract][Full Text] [Related]
7. Genetically engineered multi-component virus-like particles as veterinary vaccines. Pearson LD; Roy P Immunol Cell Biol; 1993 Oct; 71 ( Pt 5)():381-9. PubMed ID: 8270267 [TBL] [Abstract][Full Text] [Related]
8. Development of baculovirus triple and quadruple expression vectors: co-expression of three or four bluetongue virus proteins and the synthesis of bluetongue virus-like particles in insect cells. Belyaev AS; Roy P Nucleic Acids Res; 1993 Mar; 21(5):1219-23. PubMed ID: 8385313 [TBL] [Abstract][Full Text] [Related]
9. [Expression and characterization of two outer capsid proteins VP2 and VP5 of bluetongue virus in insect cells]. Wang J; Jiang H; Qu J Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Dec; 13(4):321-4. PubMed ID: 12759967 [TBL] [Abstract][Full Text] [Related]
10. Structure of correctly self-assembled bluetongue virus-like particles. Hewat EA; Booth TF; Roy P J Struct Biol; 1994; 112(3):183-91. PubMed ID: 7986645 [TBL] [Abstract][Full Text] [Related]
11. Subcore- and core-like particles of Broadhaven virus (BRDV), a tick-borne orbivirus, synthesized from baculovirus expressed VP2 and VP7, the major core proteins of BRDV. Moss SR; Nuttall PA Virus Res; 1994 Jun; 32(3):401-7. PubMed ID: 8079519 [TBL] [Abstract][Full Text] [Related]
12. Baculovirus multigene expression vectors and their use for understanding the assembly process of architecturally complex virus particles. Roy P; Mikhailov M; Bishop DH Gene; 1997 Apr; 190(1):119-29. PubMed ID: 9185857 [TBL] [Abstract][Full Text] [Related]
13. High level expression of the two outer capsid proteins of bluetongue virus serotype 10: their relationship with the neutralization of virus infection. Marshall JJ; Roy P Virus Res; 1990 Mar; 15(3):189-95. PubMed ID: 2160763 [TBL] [Abstract][Full Text] [Related]
14. Characterization and replicase activity of double-layered and single-layered rotavirus-like particles expressed from baculovirus recombinants. Zeng CQ; Wentz MJ; Cohen J; Estes MK; Ramig RF J Virol; 1996 May; 70(5):2736-42. PubMed ID: 8627747 [TBL] [Abstract][Full Text] [Related]
15. Expression of the outer capsid protein, VP2, from a full length cDNA clone of genome segment 2 of bluetongue serotype 1 from South Africa, using both Sp6 and vaccinia expression systems and a comparison of the nucleic acid sequence of this segment with those of other serotypes. Wade-Evans AM; Mertens PP Virus Res; 1990 Mar; 15(3):213-29. PubMed ID: 2160764 [TBL] [Abstract][Full Text] [Related]
16. Identification of domains in bluetongue virus VP3 molecules essential for the assembly of virus cores. Tanaka S; Roy P J Virol; 1994 May; 68(5):2795-802. PubMed ID: 8151751 [TBL] [Abstract][Full Text] [Related]
17. Release of bluetongue virus-like particles from insect cells is mediated by BTV nonstructural protein NS3/NS3A. Hyatt AD; Zhao Y; Roy P Virology; 1993 Apr; 193(2):592-603. PubMed ID: 8384747 [TBL] [Abstract][Full Text] [Related]
18. Evolutionary relationships among the gnat-transmitted orbiviruses that cause African horse sickness, bluetongue, and epizootic hemorrhagic disease as evidenced by their capsid protein sequences. Iwata H; Yamagawa M; Roy P Virology; 1992 Nov; 191(1):251-61. PubMed ID: 1329319 [TBL] [Abstract][Full Text] [Related]
19. Interactions between bluetongue virus core and capsid proteins translated in vitro. Liu HM; Booth TF; Roy P J Gen Virol; 1992 Oct; 73 ( Pt 10)():2577-84. PubMed ID: 1328473 [TBL] [Abstract][Full Text] [Related]
20. Sequence analysis and in vitro expression of a cDNA clone of genome segment 5 from bluetongue virus, serotype 1 from South Africa. Wade-Evans AM; Pan ZQ; Mertens PP Virus Res; 1988 Oct; 11(3):227-40. PubMed ID: 2848383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]